Several meta-analyses have shown that Nf-L is significantly elevated in several neurodegenerative diseases, including Charcot-Marie-Tooth disease, Guillain–Barre syndrome, Parkinson disease, and multiple sclerosis [20, 21]. This evidence concerns the gene NEFL and neurodegenerative disease.